Attached files
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION
906
OF THE SARBANES-OXLEY ACT OF
2002
In connection with
this Quarterly Report of MusclePharm Corporation (the
“Company”), on Form 10-Q for the period ended June 30,
2017, as filed with the U.S. Securities and Exchange Commission on
the date hereof (the “Report”), I, Douglas West,
interim Principal Financial Officer of the Company, certify
pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to
Section. 906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge:
|
(1)
|
The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,
as amended; and
|
|
(2)
|
The information contained in the Report, fairly
presents, in all material respects, the financial condition and
results of operations of the Company.
|
|
|
|
|
Date: August 14, 2017
|
|
By:
|
/s/
Douglas West
|
|
|
|
Douglas West
|
|
|
|
V.P of Finance and
Administration
(Interim Principal
Financial Officer and Principal Accounting Officer)
|
|
|
|
|
|
|
|
|
|
|
|
|